遗传性血管炎与正常的C1抑制剂,与carboxypeptidase N缺乏相关
Denis Vincent1,2, Faidra Parsopoulou3,4, Ludovic Martin5,6
1Allergy and Internal Medicine Unit, University Hospital, Nîmes, France.
与CPN1基因变异相关的遗传性碳氧胺酶N (CPN) 缺陷,导致具有正常C1抑制剂 (HAE-nC1-INH) 的遗传性血管. 这种缺乏可能导致布拉迪基宁的积累,引发血管和疹症状.
科学领域:
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 具有正常C1抑制剂 (HAE-nC1-INH) 的遗传性血管炎是一种罕见的,可能致命的疾病,导致复发性胀.
- 对于HAE-nC1-INH的遗传原因仍然在很大程度上是未知的,特别是关于布拉迪基宁代谢途径.
研究的目的:
- 在HAE-nC1-INH和carboxypeptidase N (CPN) 缺乏症的家庭中研究kallikrein-kinin系统的遗传因素和生物标记物.
- 确定与HAE-nC1-INH相关联的CPN1基因中的遗传变异.
主要方法:
- 分析了来自4个HAE-nC1-INH和CPN缺乏症家族的临床记录,kallikrein-kinin系统参数和遗传数据 (下一代和桑格测序).
- 利用预测算法来评估已识别的遗传变异的病原性.
主要成果:
- 患者表现出血管功能和疹,血CPN活性显著降低 (30-50%的中位数).
- 在受影响的家族中确定了三种CPN1基因变异 (c.533G>A,c.582A>G,c.734C>T) 与HAE-nC1-INH症状分离.
结论:
- CPN1基因变异与CPN缺陷和HAE-nC1-INH有关.
- 遗传CPN缺陷可能会通过布拉迪基宁和阿纳菲拉托克辛的积累导致血管和疹症状.
更多相关视频
06:53A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Regulation of Angiogenesis and Blood Supply
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
